Janux Therapeutics, Inc.JANXNASDAQ
Loading
R&D Expenses Over TimeExpanding
Percentile Rank100
3Y CAGR+33.1%
5Y CAGR+110.6%
Year-over-Year Change
Research and development spending
3Y CAGR
+33.1%/yr
Annual compound
5Y CAGR
+110.6%/yr
Recent deceleration
Percentile
P100
Near historical high
vs 5Y Ago
41.4x
Strong expansion
Streak
6 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $125.90M | +84.1% |
| 2024 | $68.39M | +24.5% |
| 2023 | $54.92M | +2.8% |
| 2022 | $53.44M | +103.7% |
| 2021 | $26.24M | +762.8% |
| 2020 | $3.04M | +1.4% |
| 2019 | $3.00M | - |